Skip to content

Ultrasound detection of lipohypertrophy characterization and its effect on glycemic variability in diabetes with insulin injection

Ultrasound detection of lipohypertrophy characterization and its effect on glycemic variability in diabetes with insulin injection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048886
Enrollment
Unknown
Registered
2021-07-19
Start date
2021-08-10
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

health checkup group:health checkup

Sponsors

Joint Logistic Support Force 900th Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old, male or female; 2. Meet the 1999 World Health Organization diagnostic criteria for diabetes; 3. Patients who have received subcutaneous injection of insulin into their abdomen at least once a day for more than 1 year; 4.Voluntarily participate in the study, and sign the relevant informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe complications such as acute infection and ketoacidosis; 2. Current use of glucagon-like peptide-1 (GLP-1) receptor agonists requiring subcutaneous abdominal injection; 3. Patients with known abdominal masses, such as lipoma, cortical gland cyst, subcutaneous cyst, etc; 4. Complicated with inflammatory abdominal skin lesions such as psoriasis and eczema; 5. Known or likely to be allergic to medical ultrasound couplings; 6. General information collection or clinical physical examination cannot be completed; 7. Patients with previous abdominal surgery and obvious scar; 8. Frequent or recent severe hypoglycemia; 9. Pregnant women; 10. Concomitant mental illness and cognitive dysfunction and inability to take care of themselves.

Design outcomes

Primary

MeasureTime frame
Number of subcutaneous fat hyperplasia;

Countries

China

Contacts

Public ContactWang Wei

Department of Endocrinology, Joint Logistic Support Force 900th Hospital

xu98111@163.com+86 15618155363

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026